In-Vitro毒性試験の世界市場レポート 2024年

In-Vitro毒性試験の市場規模は近年急速に拡大しています。2023年の103億1,000万米ドルから2024年には114億6,000万米ドルへと、CAGR11.1％で拡大します。過去の期間に見られた拡大は、規制の義務化、動物福祉に関する倫理的配慮、コストと時間の効率化、製薬業界の世界化、創薬と開発における需要、環境毒素に関する社会的意識の高まりに起因しています。

北米は、2023年のIn-Vitro毒性試験市場において最大の地域でした。アジア太平洋は、予測期間中、In-Vitro毒性試験市場レポートにおいて最も急成長する地域となる見込みです。In-Vitro毒性試験市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のIn-Vitro毒性試験市場の促進要因と制約要因
  • 促進要因
  • 抑制要因
• 実績：市場規模と成長（2018年～2023年）
• 予測：市場規模と成長（2023年～2028年、2033年）

第6章 市場セグメンテーション

• 世界のIn-Vitro毒性試験市場：製品およびサービス別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）
• 消耗品
• アッセイ
• 機器
• ソフトウェア
• サービス
• 世界のIn-Vitro毒性試験市場：技術別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）
• 細胞培養技術
• ハイスループット技術
• トキシコゲノミクス
• 世界のIn-Vitro毒性試験市場：用途別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）
• 神経毒性
• 経皮毒性
• 細胞毒性
• その他の用途
• 世界のIn-Vitro毒性試験市場：業界別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）
• 医薬品・バイオ医薬品
• 化粧品・家庭用品
• 食品
• 化学薬品

第7章 地域別および国別の分析

• 世界のIn-Vitro毒性試験市場：地域別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）
• 世界のIn-Vitro毒性試験市場：国別 - 実績と予測（2018年～2023年、2023年～2028年、2033年）

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• In-Vitro毒性試験市場の競合情勢
• In-Vitro毒性試験市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Laboratory Corporation of America Holdings（LabCorp）
  • Gentronix Limited
  • Bio-Rad Laboratories Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

In-Vitro Toxicology Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro toxicology testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product and Service: Consumables; Assays; Equipment; Software; Services
• 2) By Method: Cellular Assays; Biochemical Assays; In Silico Models; Ex Vivo Models
• 3) By Technology: Cell Culture Technologies; High-throughput Technologies; Toxicogenomics
• 4) By Applications: Neurotoxicity; Dermal toxicity; Cytotoxicity; Other Applications
• 5) By Industry: Pharmaceuticals and Biopharmaceuticals; Cosmetic and Household Products; Food; Chemicals
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (LabCorp); Gentronix Limited (a subsidiary of Eurofins Scientific SE); Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

In-vitro toxicology testing encompasses a range of assays and tests utilized to determine toxic dosages of substances like drugs, nutraceuticals, and food additives, identifying their potential toxicity upon administration. Its primary goal is to detect the presence of harmful chemicals and residual solvents, effectively reducing exposure to hazardous elements. This form of testing is predominantly employed in assessing medication doses that demonstrate toxicity during preclinical development, drug discovery, and development stages.

The core products within in-vitro toxicology testing comprise consumables, assays, equipment, software, and services. Consumables encompass various products utilized in laboratory testing procedures, including items like cannulas and lancets for compound analysis. The methods employed consist of cellular assays, biochemical assays, in silico models, and ex vivo models, employing technologies such as cell culture and high-throughput methodologies. These techniques are applied across various applications, encompassing neurotoxicity, dermal toxicity, cytotoxicity, and other related domains. The industry verticals served include pharmaceuticals, biopharmaceuticals, cosmetics, household products, food, and chemicals.

The in-vitro toxicology testing market research report is one of a series of new reports from The Business Research Company that provides in-vitro toxicology testing market statistics, including in-vitro toxicology testing industry global market size, regional shares, competitors with an in-vitro toxicology testing market share, detailed in-vitro toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro toxicology testing industry. This in-vitro toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro toxicology testing market size has grown rapidly in recent years. It will grow from $10.31 billion in 2023 to $11.46 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The expansion observed in the historical period can be attributed to regulatory mandates, ethical considerations regarding animal welfare, cost and time efficiency, the globalization of the pharmaceutical industry, demands in drug discovery and development, and heightened public awareness concerning environmental toxins.

The in-vitro toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. Anticipated growth in the upcoming period is driven by a heightened emphasis on personalized medicine, increased demand for predictive toxicology models, the expansion of environmental testing, challenges encountered in oncology drug development, and a focused approach toward endocrine disruptor screening. Key trends expected in this period encompass advancements in 3D cell culture technologies, the integration of high-throughput screening methodologies, a concentrated effort on organ-on-a-chip technologies, applications in chemical safety assessment, utilization of human-derived cell lines, incorporation of omics technologies, and the implementation of educational initiatives and training programs.

Anticipated growth in the in-vitro toxicology testing market is attributed to the escalating healthcare expenditure worldwide. This expenditure refers to the money allocated from individuals and government budgets towards hospitals, prescription drugs, nursing facilities, and healthcare services. A March 2022 report by the Centers for Medicare & Medicaid Services projected a steady annual increase of 5.1% in national health spending between 2021 and 2030, reaching approximately $6.8 trillion. Within this, Medicare spending is expected to rise at a 7.2% annual pace, while Medicaid spending is estimated to increase at a 5.6% annual rate. This upward trend in healthcare expenditure fuels the demand for in-vitro toxicology testing due to the growing prevalence of diseases.

The in-vitro toxicology testing market is set to experience a boost owing to the expanding pharmaceutical industry. This sector, responsible for researching, developing, producing, and marketing pharmaceutical drugs, is witnessing an increased demand for in-vitro toxicology testing services. These services play a critical role in screening new drug candidates and ensuring the safety of existing products. A March 2022 report by Atradius revealed that the US pharmaceutical market represents roughly 45% of the global market and contributes to 22% of the world's production, signifying significant growth potential in driving the demand for in-vitro toxicology testing within this industry.

A prominent trend in the in-vitro toxicology market is the development of innovative cell culture systems. Key players in this market are focused on pioneering technological solutions to solidify their positions. For instance, in August 2021, Amerigo Scientific, operating in the in-vitro toxicology testing realm, introduced cutting-edge vitro 3D cell culture technology. This innovative solution, facilitating precision medicine approaches, accommodates human and animal cells, offering a viable alternative that reduces small animal studies in drug development, aligning with ethical and economic considerations.

Major companies in the in-vitro toxicology testing market are adopting strategic partnership approaches to deliver 3D in-vitro services to various stakeholders. Strategic partnerships involve leveraging mutual strengths and resources for collective benefits and success. In January 2021, Charles River, a US-based provider of pharmaceutical products and services, collaborated with Cypre Inc., a biotechnology company. This collaboration enables Charles River to offer Cypre's exclusive 3D tumor model platform, Falcon, to its clients, enhancing the company's 3D in-vitro testing capabilities, specifically in immuno-oncology. Utilizing proprietary techniques, including Cypre's patented 3D hydrogel patterning technology, the platform replicates tumor microenvironments, facilitating predictive screening of novel immuno-oncology drugs.

In December 2021, Aragen Life Sciences Private Limited, an R&D and manufacturing solutions provider based in India, successfully acquired Intox Private Limited for an undisclosed sum. This strategic acquisition serves to broaden Aragen's offerings in integrated drug discovery and development toxicology services specifically catered to pharmaceutical companies. Intox Private Limited, another India-based entity, specializes in in-vitro toxicology testing and was the target of this acquisition by Aragen Life Sciences.

Major companies operating in the in-vitro toxicology testing market report are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Abbott Laboratories, Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Quest Diagnostics Incorporated, Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation

North America was the largest region in the in- vitro toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro toxicology testing market includes revenues earned by entities by providing metabolic, toxicokinetic, and bioanalytical investigations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. In-Vitro Toxicology Testing Market Characteristics

3. In-Vitro Toxicology Testing Market Trends And Strategies

4. In-Vitro Toxicology Testing Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global In-Vitro Toxicology Testing Market Size and Growth

• 5.1. Global In-Vitro Toxicology Testing Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global In-Vitro Toxicology Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global In-Vitro Toxicology Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. In-Vitro Toxicology Testing Market Segmentation

• 6.1. Global In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Consumables
• Assays
• Equipment
• Software
• Services
• 6.2. Global In-Vitro Toxicology Testing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cell Culture Technologies
• High-throughput Technologies
• Toxicogenomics
• 6.3. Global In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Neurotoxicity
• Dermal toxicity
• Cytotoxicity
• Other Applications
• 6.4. Global In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceuticals and Biopharmaceuticals
• Cosmetic and Household Products
• Food
• Chemicals

7. In-Vitro Toxicology Testing Market Regional And Country Analysis

• 7.1. Global In-Vitro Toxicology Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global In-Vitro Toxicology Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific In-Vitro Toxicology Testing Market

• 8.1. Asia-Pacific In-Vitro Toxicology Testing Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China In-Vitro Toxicology Testing Market

• 9.1. China In-Vitro Toxicology Testing Market Overview
• 9.2. China In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India In-Vitro Toxicology Testing Market

• 10.1. India In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan In-Vitro Toxicology Testing Market

• 11.1. Japan In-Vitro Toxicology Testing Market Overview
• 11.2. Japan In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia In-Vitro Toxicology Testing Market

• 12.1. Australia In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia In-Vitro Toxicology Testing Market

• 13.1. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea In-Vitro Toxicology Testing Market

• 14.1. South Korea In-Vitro Toxicology Testing Market Overview
• 14.2. South Korea In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe In-Vitro Toxicology Testing Market

• 15.1. Western Europe In-Vitro Toxicology Testing Market Overview
• 15.2. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK In-Vitro Toxicology Testing Market

• 16.1. UK In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany In-Vitro Toxicology Testing Market

• 17.1. Germany In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France In-Vitro Toxicology Testing Market

• 18.1. France In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy In-Vitro Toxicology Testing Market

• 19.1. Italy In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain In-Vitro Toxicology Testing Market

• 20.1. Spain In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe In-Vitro Toxicology Testing Market

• 21.1. Eastern Europe In-Vitro Toxicology Testing Market Overview
• 21.2. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia In-Vitro Toxicology Testing Market

• 22.1. Russia In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America In-Vitro Toxicology Testing Market

• 23.1. North America In-Vitro Toxicology Testing Market Overview
• 23.2. North America In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA In-Vitro Toxicology Testing Market

• 24.1. USA In-Vitro Toxicology Testing Market Overview
• 24.2. USA In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada In-Vitro Toxicology Testing Market

• 25.1. Canada In-Vitro Toxicology Testing Market Overview
• 25.2. Canada In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America In-Vitro Toxicology Testing Market

• 26.1. South America In-Vitro Toxicology Testing Market Overview
• 26.2. South America In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil In-Vitro Toxicology Testing Market

• 27.1. Brazil In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East In-Vitro Toxicology Testing Market

• 28.1. Middle East In-Vitro Toxicology Testing Market Overview
• 28.2. Middle East In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa In-Vitro Toxicology Testing Market

• 29.1. Africa In-Vitro Toxicology Testing Market Overview
• 29.2. Africa In-Vitro Toxicology Testing Market, Segmentation By Product and Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa In-Vitro Toxicology Testing Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa In-Vitro Toxicology Testing Market, Segmentation By Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. In-Vitro Toxicology Testing Market Competitive Landscape And Company Profiles

• 30.1. In-Vitro Toxicology Testing Market Competitive Landscape
• 30.2. In-Vitro Toxicology Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck KGaA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Laboratory Corporation of America Holdings (LabCorp)
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Gentronix Limited
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bio-Rad Laboratories Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global In-Vitro Toxicology Testing Market Competitive Benchmarking

32. Global In-Vitro Toxicology Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Toxicology Testing Market

34. In-Vitro Toxicology Testing Market Future Outlook and Potential Analysis

• 34.1 In-Vitro Toxicology Testing Market In 2028 - Countries Offering Most New Opportunities
• 34.2 In-Vitro Toxicology Testing Market In 2028 - Segments Offering Most New Opportunities
• 34.3 In-Vitro Toxicology Testing Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer